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Osteoporosis is a disease characterized by a decrease in bone mineral density,
thereby increasing the risk of sustaining a fragility fracture. Most medical therapies
are systemic and do not restore bone in areas of need, leading to undesirable side
effects. Injectable hydrogels can locally deliver therapeutics with spatial precision,
and this study reports the development of an injectable hydrogel containing a
peptide mimic of bone morphogenetic protein-2 (BMP-2). To create injectable
hydrogels, hyaluronic acid was modiﬁed with norbornene (HANor) or tetrazine
(HATet) which upon mixing click into covalently crosslinked Nor-Tet hydrogels. By
modifying HANor macromers with methacrylates (Me), thiolated BMP-2 mimetic
peptides were immobilized to HANor via a Michael addition reaction, and coupling
was conﬁrmed with 1H NMR spectroscopy. BMP-2 peptides presented in soluble
and immobilized form increased alkaline phosphatase (ALP) expression in MSCs
cultured on 2D and encapsulated in 3D Nor-Tet hydrogels. Injection of bioactive
Nor-Tet hydrogels into hollow intramedullary canals of Lewis rat femurs showed a
local increase in trabecular bone density as determined by micro-CT imaging. The
presented work shows that injectable hydrogels with immobilized BMP-2 peptides
are a promising biomaterial for the local regeneration of bone tissue and for the
potential local treatment of osteoporosis.
KEYWORDS

osteoporosis, injectable hydrogels, hyaluronic acid, BMP-2, DWIVA peptides, bone
regeneration

1 Introduction
Osteoporosis is characterized by a reduction in bone mineral density and disruption
of bone microarchitecture (Wright et al., 2014). Osteoporosis is the most common
chronic metabolic bone disease with an estimated 200 million people affected worldwide
(Sozen et al., 2017). According to the International Osteoporosis Foundation, 1 in
3 women above the age of 50 and 1 in every 5 men will experience fragility fractures
resulting from osteoporosis in their lifetime (Cooper, 1999). Osteoporosis increases the
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bone formation (Seol et al., 2006; Lee et al., 2009; Madl et al.,
2014). Seol et al. (2006) found that osteoblast-like MC3T3-E1
cells cultured on titanium (Ti) chemically modiﬁed with DWIVA
peptides had higher levels of ALP, and DWIVA-treated Ti dental
implants induced increased bone formation in vivo. MSCs
encapsulated in DWIVA-functionalized self-assembling
nanoﬁbrous hydrogel networks and alginate hydrogels also
commit to osteogenic lineages, as evidenced by increased ALP
activity and mineralization (Lee et al., 2009; Madl et al., 2014).
Hyaluronic acid (HA) is an abundant extracellular matrix
component that mediates cellular signaling, matrix organization,
and morphogenesis (Toole, 2001, 2004). HA polymers are
amenable to chemical modiﬁcations through carboxyl and
hydroxyl functional groups that can be used as macromers to
create highly tunable hydrogels via various polymerization
schemes (Burdick and Prestwich, 2011; Highley et al., 2016).
For instance, Diels-Alder reactions between macromers modiﬁed
with dienes (e.g., Nor) and dienophiles (e.g., Tet) yield selfforming hydrogels that can be injected (Alge et al., 2013; Desai
et al., 2015). In this study, we hypothesize that HA modiﬁed with
Nor or Tet moieties can be used to create injectable DWIVAfunctionalized Nor-Tet hydrogels that enhance osteogenic
differentiation of MSCs in vitro and induce trabecular bone
growth in vivo. To test this hypothesis, we developed an
injectable HA hydrogel system by modifying HA with Nor
(HANor) or Tet (HATet) moieties. BMP-2 signals were
immobilized in the hydrogels by methacrylating HANor
macromers (HANorMe) and pre-coupling Me-groups with
thiolated DWIVA peptides via an aqueous Michael addition
reaction. Osteogenic differentiation of MSCs cultured atop or
within DWIVA-functionalized hydrogels were investigated by
quantifying ALP via ﬂuorescent imaging-based analysis. New
trabecular bone formation in rat femurs injected with HA NorTet hydrogels with or without DWIVA peptide was also
evaluated using micro-computed tomography (micro-CT).

chances of fragility fractures after a low-level fall, with a mortality
rate of up to 69% within 10 years (Rachner et al., 2011). Risk
factors for osteoporosis include genetics, being of
postmenopausal age, substance abuse, poor dietary intake, and
inactivity (Van der Voort et al., 2001). These risk factors disrupt
bone remodeling, a dynamic physiological process in which bone
tissue is resorbed by osteoclasts and formed by osteoblasts
(Corral et al., 1998; Sozen et al., 2017). In osteoporosis, the
rate of bone resorption is greater than the rate of bone formation,
especially in major weight-bearing bones including vertebrae in
the lumbar spine and femurs (Deligianni et al., 1991; Sozen et al.,
2017). In the early stages of osteoporosis, bone loss is mainly
observed in trabecular or cancellous bone, made up of a
trabeculae network with high bone turnover (Li and Aspden,
1997; Zebaze et al., 2010; Osterhoff et al., 2016). Current
treatments for osteoporosis are antiresorptive and anabolic
drugs which can cause systemic side effects including
oncogenesis (Sozen et al., 2017; Tu et al., 2018). Hormonal
therapies (e.g., estrogen supplementation) are used as a last
resort and only prescribed to high-risk post-menopausal
women because it can cause adverse side effects including
blood clots (Sozen et al., 2017).
Efforts to develop alternative strategies to regenerate bone
have utilized recombinant human bone morphogenetic protein 2
(BMP-2), a potent inducer of osteogenesis in vivo (Murakami
et al., 2003; Takahashi et al., 2005; Tsuji et al., 2006; Kwong et al.,
2009; Mehta et al., 2012). The osteogenic signaling cascade begins
when BMP-2 binds to BMP-receptor type II, which leads to the
phosphorylation (activation) of BMP-receptor type I, and
ultimately to the phosphorylation of Smad1, a cytoplasmic
signaling molecule for BMP-2. Phosphorylated Smad1 then
localizes to the nucleus and controls gene expression to
initiate osteogenic differentiation (Wrana, 2000; Ito and
Miyazono, 2003; Waite and Eng, 2003). In vitro, embryonic
stem cells, human mesenchymal stem cells (MSCs), and
C2C12 myoblasts exposed to BMP-2 express increased levels
of cytoplasmic ALP, a well-established biomarker of osteogenesis
(Zhao et al., 2006; Park et al., 2010). Despite its osteoinductive
properties, the clinical use of BMP-2 is limited by unwanted side
effects. For instance, collagen scaffolds with high doses of
untethered BMP-2 used for spinal fusions have resulted in
serious complications including ectopic bone formation and
impaired neurological function (Shields et al., 2006; Garrison
et al., 2007; Wong et al., 2008).
BMP-2 is a large and expensive growth factor, and BMP-2
based therapies are associated with inconsistent outcomes and
safety concerns. Peptides that mimic the bioactivity of native
BMP-2 are an inexpensive and potentially more efﬁcacious
substitute that can be incorporated into biomaterials.
Speciﬁcally, the DWIVA peptide sequence from BMP-2 has
high receptor-binding activity and speciﬁcity to BMP-receptor
types I and II (Lee et al., 2009), and several groups have explored
the use of this sequence to enhance osteogenic differentiation and
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2 Materials and methods
2.1 Materials
Sodium hyaluronate (NaHA, 60 kDa, HA60K-5) was
purchased from Lifecore Biomedical (Chaska, MN).
Dowex® resin 50WX8 hydrogen form, 100–200 mesh,
methacrylic anhydride (MA), triethanolamine (TEOA),
and Fast Blue RR Assay (fast blue) were purchased from
Sigma Aldrich (Burlington, MA). Dimethyl sulfoxide
(DMSO),
benzotriazole-1-yl-oxy-tris-(dimethylamino)phosphonium
hexaﬂuorophosphate
(BOP),
β(N-morpholino)ethanesulfonic acid (MES), and SpectraPor
6–8 kDa molecular weight cutoff dialysis tubing were
purchased from Millipore Sigma (St. Louis, MO).
Tetrabutylammonium hydroxide (TBA-OH) was purchased
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0.5 mmol Tet per g of HATBA and reacted overnight at room
temperature. The HATet solution was then dialyzed with
SpectraPor dialysis tubing, frozen, and lyophilized. 1H NMR
spectroscopy analysis conﬁrmed that ~40% of HATet repeat
units were functionalized with Tet. The percentage of
modiﬁcation was calculated by comparing the integral of the
methyl HA peaks between δ 1.8–2.0 ppm to the carboxyl proton
peak of tetrazine between δ 10.0 and 10.5 ppm and aromatic
proton peak of tetrazine between δ 7.0 and 8.5 ppm (Koshy et al.,
2016).

from Acros Organics (Geel, Belgium). 5-norbornene-2methylamine (Nor-NH 2 ) and N-hydroxysuccinimide
(NHS) were purchased from TCI America (Portland, OR).
1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC) and
Hoechst were purchased from Thermo Scientiﬁc (Waltham,
MA). Tetrazine-amine (Tet-NH 2 ) was purchased from
Kerafast (Boston, MA). Thiol-containing peptide mimic of
BMP-2 with sequence GCGGGDWIVAG (DWIVA) was
purchased from GenScript (Piscataway, NJ). Human MSCs
from bone marrow and Osteogenic Differentiation
BulletKit TM Medium (OS Medium) were purchased from
Lonza (Walkersville, MD). Minimum essential medium
alpha (MEM-α) with no nucleosides, penicillin/
streptomycin (10,000 U/ml), and fetal bovine serum (FBS)
were purchased from Gibco (Waltham, MA). Silicone
elastomer, SylgardTM 184 was purchased from Electron
Microscopy Sciences (Hatﬁeld, PA). Isoﬂurane solution
and 70% isopropyl alcohol were purchased from Covetrus
(Portland, ME). Buprenorphine SR 1 mg/ml and meloxicam
SR 2 mg/ml were purchased from ZooPharm (Laramie, WY).
2% chlorohexidine was purchased through Covetrus
(Portland, ME) and supplied by Vedco (Saint Joseph, MO).

2.2.3 HANorDWIVA
Hydroxyl groups in HANor were ﬁrst modiﬁed with Me to
form HANorMe via esteriﬁcation with MA by adapting a
previously described protocol (Smeds and Grinstaff, 2000).
HANor was dissolved (1% w/v) in distilled water at 4°C. A
15-fold molar excess of MA was added dropwise while
maintaining pH between 8.5 and 9.0. After all MA was added,
the solution was left stirring overnight at room temperature. The
HANorMe solution was then dialyzed with SpectraPor dialysis
tubing, frozen, and lyophilized. 1H NMR spectroscopy analysis
conﬁrmed that ~60% of HANorMe repeat units were
functionalized with Me. The percentage of modiﬁcation was
calculated by comparing the integral of the HA peaks between
δ 1.8–2.0 ppm to the alkene proton peaks of Me between δ
5.5–6.5 ppm (Youseﬁ et al., 2018).
To peptide-functionalize HANorMe, thiols in cysteinecontaining peptides were coupled to Me groups in HANorMe
via an aqueous Michael addition reaction (Li et al., 2010). Brieﬂy,
HANorMe was dissolved (1% w/v) in 200 mM TEOA buffer
(pH 8) at room temperature. Thiolated DWIVA (sequence:
GCGGGDWIVAG) in solution (50 mM in PBS) was added
dropwise to reach a ﬁnal DWIVA concentration that
corresponds to an effective concentration of either 0.50 mM
or 2 mM for 2% w/v HA Nor-Tet hydrogels (Supplementary
Table S1) (Lee et al., 2009; Madl et al., 2014). The
HANorDWIVA solution was then dialyzed with SpectraPor
dialysis tubing, frozen, and lyophilized. 1H NMR spectroscopy
analysis conﬁrmed that 5% (for 0.5 mM) and 16% (for 2 mM) of
Me groups were coupled with DWIVA. The percentage of MeDWIVA coupling was calculated by comparing the integral of
alkene proton peaks of Me between δ 5.5–6.5 ppm (Youseﬁ et al.,
2018) to the protons in the amino group of cysteine moiety
between δ 0.50–1.50 ppm (Madl et al., 2014).

2.2 Hydrogel macromer synthesis and
characterization
2.2.1 HANor
Carboxyl groups in HA were modiﬁed with Nor as previously
described (Vega et al., 2018). Brieﬂy, NaHA was converted to its
tetrabutylammonium salt (HATBA) by dissolving in distilled
water (2% w/v) and mixing with Dowex resin (3 g resin per 1 g
NaHA) for two hours at room temperature. The resin was then
vacuum ﬁltered, and the pH was adjusted to 7.02 using TBA-OH
diluted in water (1:1 v/v). The resulting HATBA solution was
frozen and lyophilized. Carboxyl groups in HATBA were then
modiﬁed with Nor via amidation with Nor-NH2 (0.4 mmol per
1 g of HATBA) in anhydrous DMSO (0.5 ml per 0.1 g HATBA)
and BOP (0.38 g per 1 g HATBA) under nitrogen for two hours
at room temperature. The reaction was quenched with cold
distilled water, dialyzed with SpectraPor dialysis tubing,
frozen, and lyophilized. The synthesized HANor macromer
had ~50% of its repeat units functionalized with Nor, as
analyzed with 1H NMR spectroscopy. The percentage of
modiﬁcation was calculated by comparing the integral of the
methyl HA peaks between δ 1.8–2.0 ppm to the vinyl proton
peaks of Nor between δ 6.2–6.3 ppm (Miao et al., 2015).

2.3 Characterization of Nor-Tet hydrogels

2.2.2 HATet

To characterize the hydrogels, rheology and compression
mechanical testing were performed. Rheological properties of
Nor-Tet hydrogels were measured using a Discovery Hybrid
Rheometer (DHR-3, TA Instruments, New Castle, DE) with a
20 mm diameter 1° cone upper plate geometry and a lower plate

Carboxyl groups in HA were modiﬁed with Tet using a
modiﬁed procedure previously described (Desai et al., 2015).
Brieﬂy, HATBA was dissolved (1% w/v) in 100 mM MES buffer
(pH 6). EDC, NHS, and Tet-NH2 were added at a 1:4:1 M ratio at
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temperature of 37°C. Samples were prepared by dissolving
HANor (with or without DWIVA functionalization) and
HATet separately in PBS, followed by mixing at a 1:
1 stoichiometric ratio, resulting in a ﬁnal macromer
concentration of 2% w/v. Immediately after mixing, 40 µl of
the solution was pipetted to the center of the rheometer stage and
the shear storage (G′) and loss (G″) moduli were monitored. To
measure plateau G′ and gelation kinetics, time sweeps were
performed for 1 h at 1 Hz and 1% oscillatory strain. Bulk
mechanical properties of 2% w/v self-forming hydrogels were
measured using an EZ-SX Mechanical Tester (Shimadzu, Long
Beach, CA) equipped with a 50 N compression load. Brieﬂy,
hydrated HANor or HANorDWIVA and HATet were mixed and
pipetted into cylindrical polydimethylsiloxane (PDMS) molds
(2 mm height, 8 mm diameter). The hydrogels were allowed to
form for 30 min before incubating in PBS overnight at 37°C.
Formed cylindrical Nor-Tet hydrogels were compressed until
30% strain, and the elastic modulus (E) was determined using the
slope of the stress-strain curve between 10% and 20% strain.

stained for double stranded DNA with Hoechst (1:1000) for
5 min (glass, 2D hydrogels) or 15 min (3D hydrogels).
Acquisition of immunoﬂuorescence images was performed
with a Nikon A1 confocal microscope. Images were taken at
20 × magniﬁcation and at laser wavelengths of 405 nm (nuclei)
and 640 nm (ALP) (glass, 2D and 3D hydrogels). Image stacks
were taken at height of 200 µm with a step size of 3.2 µm (3D
hydrogels).
Mean ﬂuorescence intensity (MFI) of cellular ALP was
determined using ImageJ software (National Institute of
Health, Bethesda, MD, United States). Brieﬂy, nuclei stacks
were binarized using the Otsu thresholding method. Binarized
nuclei stacks were dilated, and the nuclei stacks were subtracted
from the dilated stacks resulting in rings. The rings were
converted into masks and overlayed on the ALP channel
stacks. The 3D Objects Counter feature was then applied to
calculate the surface area of the rings and the Measure function
was used to determine the integrated density of the rings. The
MFI value of every cell was calculated by dividing its mean grey
value by area. The MFI values of Growth Medium and OS
Medium groups were processed using a k-means clustering
algorithm to determine the boundary between MSCs with low
(ALP-negative) and high (ALP-positive) MFI. The selected
threshold MFI covers 95% of ALP-negative cells (Vega et al.,
2012).

2.4 Cell culture
Human primary MSCs were cultured in 100 mm petri dishes
in Growth Medium (MEM-α supplemented with 10% FBS and
1% P/S). To study the effects of soluble DWIVA on stem cell
cultures, MSCs were seeded on top of glass coverslips (12 mm
diameter) at a density of 3,000 cells per cm2. After 6 h in culture,
media was replaced with either Growth Medium (0 mM
DWIVA), Growth Medium supplemented with low (0.50 mM)
or high (2.0 mM) DWIVA, or OS Medium.
To study the effects of tethered DWIVA on 2D hydrogel
cultures, 2% w/v HA Nor-Tet hydrogels with varying degrees of
DWIVA functionalization (0, 0.5, 2 mM) were formed on PDMS
molds (11 mm diameter, 1 mm height) for 30 min followed by
incubation in Growth Medium for 30 min at 37°C. MSCs were
seeded on top of these hydrogels at a density of 3,000 cells per
cm2. To study the effects of DWIVA in 3D hydrogel cultures,
MSC-laden (2 × 106 cells/ml) 2% w/v Nor-Tet hydrogels with
varying degrees of DWIVA functionalization (0, 0.5, 2 mM) were
formed on PDMS molds (8 mm diameter, 2 mm height) for
2 min followed by incubation in Growth Medium for 30 min at
37°C. Appropriate media were replenished every 48 h and all
experiments were cultured for 7 days.

2.6 Animal protocol
The animal experiment was approved by the Cooper
University Health Care’s Institutional Animal Care and Use
Committee (IACUC). Experiments were performed on 8week-old male Lewis rats (Charles River Laboratories, Raleigh,
NC) weighing approximately 275–300 g. The rats were housed in
a 12-h dark-light cycle where they had access to food and water
ad libitum. The rats were randomly divided into three groups:
drilled canal alone, injectable hydrogel, and injectable hydrogel
with 2 mM DWIVA peptide. The procedures were performed
under anesthesia using inhaled isoﬂuorane solution and
buprenorphine SR. Once anesthetized, surgical sites were
prepared by shaving the ventral aspect of the abdomen and
hind legs and scrubbed with 2% chlorohexidine and 70%
isopropyl alcohol. A standard median parapatellar approach
to bilateral knees was performed. The distal femurs were
exposed, and the femoral notch was identiﬁed. Utilizing a
1 mm sterile drill, the intramedullary canal was drilled and
checked on ﬂuoroscopy for placement. Three passes with the
drill were performed to adequately remove native bone marrow
and trabecular bone. The femurs were then ﬁlled with 0.2 ml of
2% w/v self-forming hydrogel solution via injection using a 25gauge syringe. Bone wax was placed over the hole after injection.
Closure of the arthrotomy and skin was performed with Vicryl
sutures. Following closure of the surgical sites, animals were

2.5 Staining and imaging-based analysis
After 7 days in culture, samples were ﬁxed with 10% neutral
buffered formalin for 10 min (glass, 2D hydrogels) or 30 min (3D
hydrogels) at room temperature. To visualize cellular ALP, fast
blue was added for 1 h (glass, 2D hydrogels) or 3 h (3D
hydrogels). To visualize individual nuclei, samples were
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respectively (Supplementary Figure S1). Mixing of hydrated
HANorDWIVA with hydrated HATet results in hydrogel
formation through crosslinking between Nor and Tet moieties
(Figure 1B). Material characterization of Nor-Tet hydrogels
functionalized with 0, 0.5, or 2.0 mM DWIVA shows that
mechanics and gelation time are not affected by the DWIVA
peptide. Additionally, DWIVA functionalization does not affect
the equilibrium swelling ratio of HA Nor-Tet hydrogels
(Supplementary Table S2). Frequency sweep rheology
(0.1–10 Hz) at 37°C shows constant storage modulus (G′) at
every time point for Nor-Tet hydrogels with 0, 0.5, and 2.0 mM
DWIVA, respectively (Figure 1C). Time sweep rheology (1 Hz) at
37°C shows that plateau G′ values are 1,767 ± 468, 1,630 ± 323 Pa,
and 1,517 ± 268 Pa for Nor-Tet hydrogels with 0, 0.5, and
2.0 mM DWIVA, respectively (Figure 1D). The time to 50%
plateau G′ values are 5.25 ± 0.16 min, 5.30 ± 0.24 min, and 4.93 ±
0.20 min for Nor-Tet hydrogels with 0, 0.5, and 2.0 mM DWIVA,
respectively (Figure 1E). Compression testing shows elastic
moduli (E) values of 4.12 ± 1.22 kPa, 4.38 ± 0.92 kPa, and
4.64 ± 1.07 kPa for Nor-Tet hydrogels with 0, 0.5, and
2.0 mM DWIVA, respectively (Figure 1F).

given meloxicam SR (2 mg/ml) for pain alleviation and
subsequently returned to their housing where they were
monitored until they recovered from the surgical anesthesia.
All rats were euthanized 4 weeks post-injection and the left and
right femurs were harvested. The femurs were ﬁxed with 10%
neutral-buffered formalin for 24 h, washed with distilled water,
and stored in 70% ethanol at 4°C until micro-CT imaging.

2.7 Micro-CT
The distal shaft (midshaft down to the metaphysis) of
extracted femurs were scanned using micro-CT (microCT 45,
ScancoMedical AG, Brüttisellen, Switzerland) at 10.4 µm
isotropic resolution, with 55 kVp energy, and 400 ms
integration time. This region was chosen to evaluate the
effects of injectable DWIVA hydrogels on trabecular bone
formation. At the center of the distal shaft, a 200-slice-thick
volume of interest (VOI) was identiﬁed, Gaussian ﬁltered
(sigma = 1.2, support = 2), and bone was identiﬁed by
applying a global threshold (220 mg hydroxyapatite per cm3).
Manufacturer-provided
software
for
3D
standard
microstructural analysis was used to generate 3D axial views
of the 200-slice-thick VOIs and coronal views of the 1031-slicethick distal shaft.

3.2 Soluble and immobilized DWIVA
enhance ALP levels of MSCs on 2D
cultures

2.8 Statistical analysis

MSCs seeded on glass cultured in Growth Medium
supplemented with 2.0 mM DWIVA show signiﬁcantly more
positive staining for ALP (dark blue) compared to cells cultured
in Growth Medium or in Growth Medium supplemented with a
lower (0.50 mM) DWIVA concentration (Figure 2A). Confocal
images of MSC cultures stained for ALP (magenta) and nuclei
(blue) show a progressive increase in ALP signal with increasing
DWIVA concentration (Figure 2B). To distinguish between
ALP(+) and ALP(−) MSCs, the mean ﬂuorescence intensity
(MFI) of intracellular ALP was ﬁrst determined for individual
MSCs using imaging-based analysis with ImageJ (Supplementary
Figure S2). The MFI values of the Growth Medium and OS
Medium groups were processed using a k-means clustering
algorithm to determine the boundary between ALP(−) and
ALP(+) clusters, resulting in an MFI cutoff value of 52, which
covers 95% of ALP(−) MSCs (Figure 2C). The MFI threshold
value is used as a ﬁlter that assigns MSCs as ALP(−) (MFI < 52)
or ALP(+) (MFI ≥ 52) (Figure 2D). Using this technique, the
percentage of ALP(+) MSCs on glass is 7.5% ± 2.1% (Growth
Medium), 14.1% ± 4.3% (0.5 mM DWIVA), 67.5% ± 3.7%
(2.0 mM DWIVA), and 92.1% ± 3.9% (OS Medium) (Figure 2E).
HANorMe was pre-functionalized with thiolated RGD
(2 mM) and with 0, 0.5, or 2 mM thiolated DWIVA. Prefunctionalized HANorMe macromers were then mixed with
HATet to form Nor-Tet hydrogels that were seeded with
MSCs (Figure 3A). Representative MSCs (ALP, magenta;

Statistical analysis was performed using GraphPad Prism
(version 9.3.1, GraphPad Software, Inc., La Jolla, CA). All
experiments were carried out in triplicate and single cell
analysis was done with at least 50 cells per group. All graphs
represent mean ± standard deviation (SD). Analysis of variance
(ANOVA) was performed followed by Tukey’s test for post-hoc
analysis. Differences among groups are stated as p < 0.05 (*), p <
0.01 (**), p < 0.001 (***), and (ns) when differences between
groups are not statistically signiﬁcant.

3 Results
3.1 Mechanics and gelation kinetics of
injectable HA hydrogels are preserved
after DWIVA coupling
The percentage modiﬁcation of HANor and HATet with Nor
and Tet was determined to be ~50% and ~40% through 1HNMR, respectively. Modiﬁcation of HANor with Me provide sites
for coupling thiolated DWIVA peptides to the HANor macromer
backbone (Figure 1A). 1H-NMR shows that HANor has a Me
modiﬁcation of ~80%. Coupling HANorMe with 0.5 and 2.0 mM
DWIVA results in 5% and 16% of Me groups bound to peptide,
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FIGURE 1
Synthesis of HANorDWIVA and characterization of DWIVA-functionalized Nor-Tet hydrogels. (A) Methacrylic anhydride is coupled to the
HANor macromer to provide sites for DWIVA to bind through Michael addition reaction. (B) Crosslinking between Nor and Tet moieties in
HANorDWIVA and HATet results in DWIVA-functionalized hydrogel. (C) Time sweep rheology of G′ kinetics is used to determine (D) plateau G′ and
(E) time to 50% plateau G′ of 0, 0.5, and 2.0 mM DWIVA-functionalized Nor-Tet hydrogels. (F) Elastic moduli of hydrogels with 0, 0.5, and
2.0 mM DWIVA. Bar graphs and scatter dot plot are shown as mean ± SD (n ≥ 3 samples per condition) with no signiﬁcant difference (ns) determined
with one-way ANOVA.

DWIVA concentration (Figure 4C). A k-means clustering
algorithm was applied for MSCs in 3D hydrogels in
Growth Medium (negative group) and OS Medium
(positive group) to determine a threshold MFI of 48, which
covers 95% of ALP(−) MSCs (Figure 4D). The percentage of
ALP(+) MSCs in 3D Nor-Tet hydrogels is 19.7% ± 3.5%
(Growth Medium), 20.4% ± 5.5% (0.50 mM DWIVA),
56.1% ± 4.6% (2.0 mM DWIVA), and 64.7% ± 4.3% (OS
Medium) (Figure 4E). Confocal images of MSCs cultured in
Growth Medium and encapsulated in Nor-Tet hydrogels
without (0 mM) or with (2 mM) DWIVA tethering show
observable differences in ALP ﬂuorescence (Figure 4F).
To evaluate bone growth in vivo, the left and right knee joints
of 8-week-old male Lewis rats were opened surgically under
sterile conditions. The intercondylar notch of each distal femur
was identiﬁed, and the intramedullary space of the femur was
cleared of native trabecular bone and bone marrow using a 1 mm
drill. (Figure 5A). Nor-Tet hydrogel solutions without peptide
(Gel group) and with 2.0 mM DWIVA peptide (Peptide group)
were injected into the left and right femurs, respectively
(Figure 5B). 4 weeks post-injection, rats were euthanized, and
femurs were harvested. Microcomputed tomography (micro-CT)
was used to image the distal shaft and to create 3D coronal views
of the distal shaft and 3D axial views of the distal shaft center
(Figure 5C). Increased trabecular bone growth is observed in
femurs injected with Peptide-containing Nor-Tet hydrogels
when compared to femurs injected with Gel alone, as seen by
3D coronal (Figure 5D) and 3D axial (Figure 5E) views.

nuclei, blue) in different treatment groups show more magenta
signal in cells atop 2D hydrogels coupled with 2.0 mM DWIVA
compared to cells atop hydrogels with lower DWIVA (0,
0.5 mM) concentrations (Figure 3B). A k-means clustering
algorithm was applied for MFI values of MSCs on Growth
Medium (negative group) and OS Medium (positive group) to
determine an MFI cutoff of 50, which covers 95% of ALP(−)
MSCs (Figure 3C). The percentage of ALP(+) MSCs on Nor-Tet
hydrogels is 12.1% ± 4.5% (0 mM DWIVA), 19.3% ± 4.5%
(0.5 mM DWIVA), 42.9% ± 3.8% (2.0 mM DWIVA), and
74.1% ± 4.1% (OS Medium) (Figure 3D).

3.3 Injectable DWIVA-functionalized NorTet hydrogels enchance ALP levels of
encapsulated MSCs and induce trabecular
bone growth
MSCs were mixed in HATet and HANor prefunctionalized with thiolated RGD (2 mM) and with 0, 0.5,
or 2 mM thiolated DWIVA and added to cylindrical molds to
form 3D cell-laden Nor-Tet hydrogels (Figure 4A). MSCs
encapsulated in 0 mM DWIVA hydrogels and cultured in
Osteogenic Medium show signiﬁcantly more positive
staining for ALP (dark blue) than those cultured in Growth
Medium (Figure 4B). MSCs cultured in Growth Medium and
encapsulated in DWIVA-functionalized HA Nor-Tet
hydrogels show an increase in ALP signal with increasing
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FIGURE 2
Soluble presentation of DWIVA enhances ALP levels of MSCs on glass. (A) Representative ALP staining of MSCs (dark blue) on glass in Growth
Medium (negative control), Growth Medium supplemented with 0.5 or 2.0 mM DWIVA, and OS Medium (positive control). (B) Representative
ﬂuorescence staining of ALP (magenta) and nucleus (blue) of MSCs on glass in Growth Medium, Growth Medium supplemented with 0.5 or 2.0 mM
DWIVA, and OS Medium. (C) Frequency distribution of ALP MFI of MSCs seeded on glass coverslips in Growth Medium (negative group) and OS
Medium (positive group); dashed line shows MFI cutoff for ALP(−) and ALP(+) cells. (D) Representative cells that are ALP(−) (top, MFI <52) and ALP(+)
(bottom, MFI ≥52). (E) % ALP(+) quantiﬁcation of MSCs cultured in Growth Medium with 0, 0.5, or 2.0 mM soluble DWIVA peptide and OS Medium. Bar
graphs are shown as mean ± SD (n ≥ 50 cells per condition) with nonsigniﬁcant differences denoted as ns, and signiﬁcant differences determined
with ANOVA followed by Tukey’s post hoc test where **p < 0.01, ***p < 0.001. Scale bars: (A) 2 mm, (B) 100 μm, (D) 20 µm.
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FIGURE 3
Immobilized DWIVA enhances ALP levels of MSCs on 2D Nor-Tet hydrogels. (A) HANor functionalized with RGD (2 mM) and DWIVA (0, 0.5, or
2 mM) were mixed with HATet, injected into cylindrical molds, and MSCs seeded atop. (B) Representative ALP (magenta) and nucleus (blue) staining
of MSCs seeded on Nor-Tet hydrogels with 0, 0.5, or 2 mM DWIVA functionalization and OS Medium positive control. (C) Frequency distribution of
ALP MFI of MSCs seeded on Nor-Tet hydrogels cultured in Growth Medium (negative group) or OS Medium (positive group); dashed line shows
MFI cutoff for ALP(−) and ALP(+) cells. (D) % ALP(+) quantiﬁcation of MSCs cultured on Nor-Tet hydrogels in Growth Medium with 0, 0.5, or 2.0 mM
immobilized DWIVA. Bar graphs are shown as mean ± SD, (n ≥ 50 cells per condition) with nonsigniﬁcant differences denoted as ns, and signiﬁcant
differences determined with ANOVA followed by Tukey’s post hoc test where **p < 0.01, ***p < 0.001. Scale bar: (B) 20 µm.

4 Discussion

S3). The 2% w/v macromer formulation used across this entire
study allows for sufﬁcient time to extrude the mixed solution
without forming inside a syringe or clogging the needle. While
this chemistry has been used to develop biocompatible
poly(ethylene glycol) (Alge et al., 2013), alginate (Desai et al.,
2015), and gelatin (Koshy et al., 2016) self-forming hydrogels, it
is challenging to incorporate bioactive motifs into Diels-Alder
hydrogels. Here, the carboxyl groups of HA were modiﬁed with
Nor and Tet, leaving the hydroxyl groups in HA free for
additional modiﬁcations. This allowed us to pre-functionalize
HANor with DWIVA by ﬁrst modifying hydroxyl groups on
HANor with Me moieties, followed by coupling with thiolated
DWIVA via a Michael-addition reaction (Figure 1A). Since

In this study, we developed DWIVA-functionalized selfforming hydrogels that enhance osteogenesis in vitro and
induce bone growth in vivo. While there are other chemistries
for forming hydrogels such as photopolymerization and
thermogelation, they require some type of catalyst while selfforming hydrogels do not. This method of forming hydrogels
makes it suitable for injectability or other applications where
catalysts may not be readily available. The hydrogel macromers
consist of HA modiﬁed with Nor or Tet moieties which upon
mixing form covalent networks by undergoing an inverse
electron demand Diels-Alder reaction (Supplementary Figure
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FIGURE 4
Immobilized DWIVA enhances ALP levels of MSCs in 3D Nor-Tet hydrogels. (A) MSCs were resuspended in RGD-functionalized HANor with or
without DWIVA coupling, mixed with HATet, and injected into cylindrical molds. Representative ALP staining of MSCs (dark blue) in 3D Nor-Tet
hydrogels with (B) 0 mM DWIVA and Growth Medium or OS Medium and (C) Growth Medium with 0.5 mM or 2.0 mM DWIVA coupling. (D)
Frequency distribution of ALP MFI of MSCs encapsulated in 3D Nor-Tet hydrogels (0 mM DWIVA) cultured in Growth Medium (negative group)
or OS Medium (positive group); dashed line shows MFI cutoff for ALP(−) and ALP(+) cells. (E) % ALP(+) quantiﬁcation of MSCs cultured in 3D Nor-Tet
hydrogels functionalized with 0, 0.5, or 2.0 mM immobilized DWIVA. (F) Representative images of single MSCs (ALP, magenta; nuclei, blue) in Growth
Medium with 0 mM or 2.0 mM DWIVA coupling. Bar graphs are shown as mean ± SD, (n ≥ 50 cells per condition) with nonsigniﬁcant differences
denoted as ns, and signiﬁcant differences determined with ANOVA followed by Tukey’s post hoc test where *p < 0.05, **p < 0.01, ***p < 0.001. Scale
bars: (B,C) 2 mm, (F) 20 µm.

DWIVA is the active motif in the wrist epitope of bone
morphogenetic protein 2 (BMP-2) (Lee et al., 2009), and growth
medium supplemented with BMP-2 causes an osteogenic
response on cultured cells (Prall et al., 2013; Samorezov et al.,
2016). Soluble BMP-2 has been incorporated with implantable
biomaterial scaffolds for bone regeneration (Shields et al., 2006;
Garrison et al., 2007; Wong et al., 2008). However, due to
diffusion of untethered BMP-2 and its short half-life, high
doses of the growth factor were required and serious
complications including ectopic bone formation were observed
(Shields et al., 2006; Garrison et al., 2007; Wong et al., 2008).
Efforts to tether growth factors are limited by low conjugation
efﬁciency and are costly (Madl et al., 2014). Alternatively, short
chain mimics of BMP-2 such as DWIVA are inexpensive to
synthesize and can be tethered easily. To evaluate the osteogenic
properties of DWIVA, MSCs were seeded on glass and cultured

DWIVA was coupled to hydroxyl groups, we hypothesized that
this should have no impact on Nor-Tet interactions from
moieties coupled to carboxyl groups of HA (Figure 1B). To
test our hypothesis, we performed rheological tests of 2% w/v HA
Nor-Tet hydrogels formed by mixing HATet with HANorMe
pre-coupled with different concentrations of DWIVA (0, 0.5,
2.0 mM) (Figures 1C–E). While there was a slight decrease in the
storage modulus (G′) and gelation time, this was not a signiﬁcant
decrease and may be due to slight variability from time taken to
mix and add solutions to the rheometer stage between samples.
HA Nor-Tet hydrogels were also pre-formed in cylindrical
molds, stored in PBS at 37°C overnight, and compression
testing was performed to measure the effects of DWIVA
coupling on elastic moduli (E) (Figure 1F). The hydrogels
retained their cylindrical geometry at physiological
temperature and DWIVA had no effect on stiffness.
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FIGURE 5
DWIVA-functionalized hydrogels induce trabecular bone growth in vivo. (A) The knee joint is exposed, and a drill is used to clear the femoral
canal. (B) The left femur is injected with Nor-Tet hydrogels (Gel group) and the right femur is injected with DWIVA-containing Nor-Tet hydrogels
(Peptide group). (C) Schematic shows 3D regions of interest that were imaged using micro-CT (blue rectangle, coronal view of distal shaft; orange
rectangle, axial view of distal shaft center). Representative micro-CT scans of (D) the distal shaft and (E) the distal shaft center of drilled femurs,
and drilled femurs injected with Gel and Peptide. Scale bars: (D), (E) 500 µm.
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stiffness does not favor osteogenesis (Engler et al., 2006). Despite
being on soft hydrogels, almost 50% of MSCs on Nor-Tet
hydrogels with a high concentration (2.0 mM) of immobilized
DWIVA were ALP(+) (Figure 3D). Future studies that evaluate
the synergistic effects of higher mechanics and immobilized
DWIVA on osteogenic differentiation may show increased
ALP(+) cells at lower DWIVA concentrations.
To investigate the osteogenic effects of immobilized DWIVA in
3D environments, MSCs were suspended in pre-hydrogel solution
consisting of HATet and HANor pre-functionalized with thiolated
RGD and different concentrations of thiolated DWIVA (0, 0.5,
2.0 mM) and extruded into molds (Figure 4A). Gross images of
0 mM DWIVA hydrogels stained for ALP show low and high levels
of ALP expression of samples cultured in Growth Medium and
Osteogenic Medium, respectively (Figure 4B). These control groups
conﬁrm that encapsulated MSCs can express ALP in the presence of
osteogenic growth factors. A qualitative observation between gross
images of hydrogels cultured in Growth Medium with low (0.5 mM)
and high (2.0 mM) DWIVA coupling display increased ALP
staining with increasing DWIVA concentration (Figure 4C).
MSCs are not only highly viable in HA Nor-Tet hydrogels postextrusion (Supplementary Figure S4), but also respond to
immobilized DWIVA in 3D self-forming hydrogels. Using the
same k-means clustering approach for the 2D studies, the
threshold MFI was determined to be 48, which is slightly lower
than the glass (MFI ≥52) and 2D hydrogel (MFI ≥50) groups.
Signiﬁcant overlap between the negative (Growth Medium) and
positive (OS Medium) relative frequency curves was also observed
(Figure 4D). Although percentage of ALP(+) MSCs increased with
increasing DWIVA concentration, only about 50% of MSCs were
classiﬁed as ALP(+), even for the OS Medium group (Figure 4E).
MSCs encapsulated in the HA Nor-Tet hydrogels remain spherical
(Figure 4F), while degradation-mediated cellular traction is
necessary for cellular spreading and osteogenesis in 3D hydrogels
(Khetan et al., 2013). MSCs encapsulated in DWIVA hydrogels
amenable to cell remodeling may be more osteoinductive than those
in restrictive hydrogels like the HA Nor-Tet hydrogels used in this
study. For example, MSCs in 3D gelatin-based Nor-Tet hydrogels
are able to remodel the surrounding hydrogel (Koshy et al., 2016),
and replacing the HA backbone of HANorDWIVA with gelatin
would allow for 3D cell spreading and DWIVA signaling.
After validating the osteogenic properties of DWIVAfunctionalized HA Nor-Tet hydrogels in vitro, we were interested
in evaluating the ability to grow bone tissue in regions prone to
osteoporotic fragility fractures. Speciﬁcally, femur fractures can lead
to a total hip replacement, and forming nascent trabecular bone in
the femur would help prevent fractures from occurring in the ﬁrst
place. To examine the effectiveness of HA Nor-Tet hydrogels in
locally regenerating bone in vivo, DWIVA-coupled self-forming
hydrogels (2 mM) were injected into hollow rat femurs (Figures
5A,B). A high DWIVA concentration was chosen since the
percentage of ALP(+) MSCs was highest at 2.0 mM DWIVA.
MSCs in HA Nor-Tet hydrogels without DWIVA

in Growth Medium supplemented with low (0.5 mM) or high
(2.0 mM) concentrations of soluble DWIVA. After 7 days in
culture, MSCs were stained for ALP, a well-established
biomarker of osteogenesis (Lee et al., 2009; Madl et al., 2014).
MSCs cultured in Growth Medium and in OS Medium served as
control groups and had the lowest and highest observable
amount of ALP, respectively (Figures 2A,B). To quantify
percentage of ALP(+) MSCs, a mean ﬂuorescence intensity
(MFI) histogram of cytoplasmic ALP from MSCs cultured in
Growth Medium (negative control) and OS Medium (positive
control) was used to identify a cutoff MFI value for ALP(+) cells
(Figure 2C). The threshold MFI was set such that 95% of MFI
values for MSCs in the ALP(−) group (Growth Medium) were
classiﬁed as ALP(−). This technique is an adaptation of a
k-means clustering-based approach to assign cells to a
subpopulation based on speciﬁc metrics (Vega et al., 2012),
and it minimizes bias for identifying ALP(+) MSCs. Using
this approach for MSCs on glass, the threshold MFI was
determined to be 52. The Growth Medium and OS Medium
ALP MFI histograms had very little overlap and had peak values
of 18 and 102, respectively (Figure 2C). Although glass is
extremely stiff and rigid substrates favor osteogenic
differentiation (Engler et al., 2006), synergy between high
mechanics and soluble DWIVA was only observed at high
(2.0 mM) DWIVA concentrations. There was no signiﬁcant
difference in ALP(+) MSCs between Growth Medium and low
(0.5 mM) DWIVA concentration, while 67% of MSCs were
ALP(+) in the high DWIVA concentration group (Figure 2E).
After demonstrating that soluble DWIVA induces increased
ALP, we evaluated the osteogenic effects of immobilized DWIVA.
Here, HANorMe was ﬁrst pre-coupled with 2 mM thiolated RGD
and different concentrations of thiolated DWIVA (0, 0.5,
2.0 mM). To form peptide-functionalized HA Nor-Tet
hydrogels, bioactive HANor was mixed with HATet and the
solution polymerized on cylindrical molds, and MSCs were
seeded on top (Figure 3A). Since MSCs do not readily adhere
to HA, all groups included 2.0 mM RGD, a peptide motif of
adhesive ﬁbronectin (Massia and Hubbell, 1990). MSCs attached
on all groups, and after 7 days increased intracellular ALP levels
were observed with increasing DWIVA concentration
(Figure 3B). To minimize bias while identifying ALP(+) MSCs,
MFI histograms of MSCs on HA Nor-Tet hydrogels cultured in
Growth Medium (negative group) and OS Medium (positive
group) were used to identify a threshold MFI (Figure 3C).
Through k-means clustering, the cutoff MFI for ALP(+) MSCs
was determined to be 50, which is slightly lower than the
threshold for the glass group (MFI ≥52). There was also
signiﬁcantly more overlap between MFI values for the negative
and positive groups, and the MFI peak for the OS Medium group
decreased from 102 to 76 (Figure 3C). The decrease in MFI for the
positive group could be attributed to the mechanical properties of
the HA Nor-Tet hydrogels. At a total macromer concentration of
2% w/v, HA Nor-Tet hydrogels were about 5 kPa, and this low
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5 Conclusion

functionalization expressed minimal ALP levels and this
formulation was injected in contralateral femurs and served as a
negative control group. 4 weeks post-injection, the femurs were
harvested and micro-CT imaging was utilized to examine the
differences in new trabecular bone growth in femurs that were
kept hollow (Drill) or injected with uncoupled (Gel) or DWIVAcoupled (Peptide) self-forming hydrogels. 3D coronal views of the
distal shaft for the Drill and Gel groups show minimal trabecular
bone along the shaft with trabeculae in the metaphysis (bottom),
whereas in the Peptide group signiﬁcant trabecular bone growth is
observed along the shaft (Figure 5D). 3D axial views of the distal
shaft center reveal almost no trabecular bone in the Drill group, with
increasing trabeculae seen in the Gel and Peptide groups (Figure 5E).
Since the Gel and Peptide groups were acellular, bone regeneration
in the trabecular space would have had to be produced by native cells
that migrated into the hydrogel. The migration of native cells into
the trabecular space may have been aided by the presence of
hyaluronidase, an enzyme that breaks down hyaluronic acid by
cleaving its glycosidic bonds, in the femoral shaft (Zhong et al.,
1994). Although DWIVA-functionalized hydrogels were exposed to
hyaluronidase in vivo, the bioactivity of the hydrogel was preserved
as shown by improved trabecular bone growth in the Peptide
group. Additionally, since hyaluronidase cleaves the glycosidic
bonds in the hyaluronic chain, exposure to the enzyme should
not interfere with DWIVA conjugation. Enzymatic degradation of
HA hydrogels in vivo could be replicated in vitro by adding
exogeneous hyaluronidase. By doing so, we will be able to
compare the degradation rate of the hydrogel with the rate of
trabecular bone formation.
Together, these ﬁndings show that injectable, DWIVAfunctionalized hydrogels can locally regenerate bone in vivo and
present opportunities for follow-up studies. Bone regeneration after
a fracture can take 6–12 weeks (Yingjie et al., 2007), and the
osteogenic effects of DWIVA at later time-points has not been
determined. Furthermore, the bioavailability of DWIVA in soluble
and tethered form has not been evaluated and it is an area that
warrants further study. While we showed that the high (2.0 mM)
DWIVA peptide concentration group displayed osteogenic
properties in vitro and in vivo, the peptide coupling chemistry
presented here can be used to evaluate the osteoinductive
properties of DWIVA at higher peptide concentrations. The HA
Nor-Tet hydrogels are amenable to 2D and 3D MSC culture, and the
inclusion of DWIVA has an osteogenic effect on resident MSCs.
Thus, it would be interesting to evaluate the synergistic effects of
MSCs and DWIVA in regenerating bone in vivo. Besides the
DWIVA wrist epitope of BMP-2, BMP-2 also has a knuckle
epitope with the active sequence KIPKASSVPTELSAISTLYLG
(KIPKA) (Lee et al., 2009; Madl et al., 2014). The KIPKA
sequence is believed to bind to BMP receptor II. Since both
receptors I and II are involved in the signaling cascade for BMP2, it would be beneﬁcial to explore the independent effect of KIPKA
and the synergistic effects of KIPKA and DWIVA sequences in
locally regenerating bone.

Frontiers in Biomaterials Science

We developed an injectable hydrogel with DWIVA, an
immobilized mimetic peptide of BMP-2, and demonstrated
that it that can regenerate trabecular bone in femurs. We ﬁrst
showed that the effective concentration of DWIVA peptide in
self-forming hydrogels can be controlled by changing the amount
of peptide added during coupling with HANorMe macromers.
We also conﬁrmed that the bioactivity of the DWIVA peptide is
preserved post-coupling by showing that ALP expression is
enhanced in human MSCs seeded atop (2D) or within (3D)
DWIVA-functionalized HA Nor-Tet hydrogels. This hydrogel
system has the potential to be used as a targeted therapeutic to
improve bone density locally, which is imperative in reducing the
incidence of osteoporotic fragility fractures.
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